News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,438 Results
Type
Article (39424)
Company Profile (249)
Press Release (653765)
Section
Business (204045)
Career Advice (2006)
Deals (35408)
Drug Delivery (93)
Drug Development (80963)
Employer Resources (169)
FDA (16138)
Job Trends (14831)
News (344919)
Policy (32479)
Tag
Academia (2537)
Alliances (49330)
Alzheimer's disease (1317)
Approvals (16124)
Artificial intelligence (208)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (177)
Breast cancer (230)
Cancer (1770)
Cardiovascular disease (132)
Career advice (1670)
CAR-T (128)
Cell therapy (368)
Clinical research (65353)
Collaboration (688)
Compensation (379)
COVID-19 (2568)
C-suite (171)
Data (1686)
Diabetes (221)
Diagnostics (6298)
Earnings (85648)
Employer resources (145)
Events (111100)
Executive appointments (583)
FDA (17078)
Funding (619)
Gene therapy (252)
GLP-1 (657)
Government (4362)
Healthcare (18783)
Infectious disease (2685)
Interviews (311)
IPO (16467)
Job creations (3627)
Job search strategy (1421)
Layoffs (440)
Legal (7890)
Lung cancer (259)
Manufacturing (241)
Medical device (13275)
Medtech (13280)
Mergers & acquisitions (19333)
Metabolic disorders (572)
Neuroscience (1734)
NextGen: Class of 2025 (6509)
Non-profit (4476)
Northern California (2177)
Obesity (314)
Opinion (196)
Patents (174)
People (56891)
Phase I (20349)
Phase II (28787)
Phase III (21436)
Pipeline (780)
Postmarket research (2563)
Preclinical (8587)
Radiopharmaceuticals (242)
Rare diseases (331)
Real estate (5897)
Regulatory (21972)
Research institute (2314)
Resumes & cover letters (349)
Southern California (1867)
Startups (3569)
United States (19133)
Vaccines (620)
Weight loss (214)
Date
Today (111)
Last 7 days (762)
Last 30 days (2687)
Last 365 days (34335)
2025 (5335)
2024 (35219)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Arizona (211)
Asia (37548)
Australia (6138)
California (4962)
Canada (1748)
China (410)
Colorado (226)
Connecticut (234)
Europe (80489)
Florida (730)
Georgia (171)
Illinois (463)
Indiana (271)
Japan (126)
Maryland (757)
Massachusetts (3768)
Michigan (200)
Minnesota (344)
New Jersey (1404)
New York (1420)
North Carolina (855)
Northern California (2177)
Ohio (174)
Pennsylvania (1128)
South America (1093)
Southern California (1867)
Texas (725)
Utah (153)
Washington State (475)
693,438 Results for "trianni inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Trianni, Inc. Announces License Agreement with Nkarta, Inc. for the Trianni Mouse®
Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement with Nkarta, Inc. (“NKARTA”) for the use of the Trianni Mouse®, a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies, to support NKARTA’s antibody-based therapeutic discovery programs.
March 10, 2020
·
1 min read
Biotech Bay
Trianni, Inc. and Mablytics, Inc. Announce License Agreement for the Trianni Mouse®
Trianni, Inc. (“TRIANNI”) and Mablytics, Inc. (“MABLYTICS”) jointly announced today that they have entered into a license agreement for the use of the Trianni Mouse®, a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies, to support MABLYTICS’ antibody-based therapeutic discovery programs.
February 4, 2020
·
1 min read
Business
Trianni, Inc. Announces License Agreement with Artizan Biosciences, Inc. for the Trianni Mouse®
Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement with Artizan Biosciences, Inc. (“Artizan”) for the use of the Trianni Mouse®, a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies, to support Artizan’s antibody-based therapeutic discovery programs.
February 25, 2020
·
1 min read
Biotech Bay
Trianni Secures an EU Patent on the Trianni Mouse® Antibody Discovery Platform
Trianni, Inc. (“TRIANNI”) announced today that the European Patent Office granted patent EP 2597945 for TRIANNI’s leading technology, The Trianni Mouse®. The Trianni Mouse is a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies.
July 22, 2020
·
1 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Business
Trianni, Inc. Announces License Agreement with Zymeworks Inc. for use of the Trianni Mouse®
Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement with Zymeworks Inc. (“ZYMEWORKS”) for the use of the Trianni Mouse®, a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies, to support ZYMEWORKS’ therapeutic discovery programs.
September 10, 2019
·
1 min read
Press Releases
Moss Genomics Inc. Announces Leadership Changes
February 26, 2025
·
5 min read
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
1 of 69,344
Next
